JAZZ
HealthcareJazz Pharmaceuticals plc
$178.92-1.40 (-0.78%)
Prev Close
$180.32
Open
$181.56
High
$183.90
Low
$177.58
Volume
455.2K
Market Cap
$11.28B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Jazz Pharmaceuticals plc (JAZZ) has been dominated by selling, with 1 insider purchase totaling $9.99M and 35 insider sales totaling $34.10M. The most recent insider transaction was by COZADD BRUCE C (Director), who sold $2.99M worth of shares on Jan 16, 2026. Jazz Pharmaceuticals plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $11.28B.
Buys (12M)
1
$9.99M
Sells (12M)
35
$34.10M
Net Activity
Net Seller
$24.11M
Active Insiders
18
last 12 mo
JAZZ Price Chart
JAZZ Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026↗ | COZADD BRUCE C | Director | Sell | 17,453 | $171.16 | $2.99M | 0 |
| Jan 16, 2026↗ | GALA RENEE D | President & CEO | Sell | 5,371 | $171.16 | $919.3K | 0 |
| Jan 16, 2026↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 4,140 | $171.16 | $708.6K | 0 |
| Jan 16, 2026↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,275 | $171.16 | $560.5K | 0 |
| Jan 16, 2026↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,599 | $171.16 | $273.7K | 0 |
| Dec 9, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 2,238 | $169.51 | $379.4K | 0 |
| Dec 5, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 4,660 | $171.20 | $797.8K | 0 |
| Dec 5, 2025↗ | GALA RENEE D | President & CEO | Sell | 80 | $166.91 | $13.4K | 0 |
| Dec 2, 2025↗ | O'Keefe Kenneth W | Director | Sell | 603 | $173.07 | $104.4K | 0 |
| Nov 26, 2025↗ | COZADD BRUCE C | Director | Sell | 77,500 | $177.81 | $13.78M | 0 |
| Nov 20, 2025↗ | McSharry Heather Ann | Director | Sell | 3,415 | $177.78 | $607.1K | 0 |
| Nov 19, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 1,331 | $180.40 | $240.1K | 0 |
| Nov 18, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 5,319 | $182.06 | $968.4K | 0 |
| Nov 18, 2025↗ | COZADD BRUCE C | Director | Sell | 18,000 | $181.09 | $3.26M | 0 |
| Nov 18, 2025↗ | Winningham Rick E | Director | Sell | 5,500 | $180.86 | $994.7K | 0 |
| Nov 17, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 7,159 | $168.26 | $1.20M | 0 |
| Oct 1, 2025↗ | COZADD BRUCE C | Director | Sell | 5,500 | $137.01 | $753.6K | 0 |
| Sep 14, 2025↗ | COZADD BRUCE C | Director | Sell | 15,647 | $126.16 | $1.97M | 0 |
| Sep 2, 2025↗ | COZADD BRUCE C | Director | Sell | 6,000 | $128.62 | $771.7K | 0 |
| Aug 7, 2025↗ | Cook Jennifer E. | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | ENRIGHT PATRICK G | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Hamill Laura | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Kennedy Patrick | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025↗ | McSharry Heather Ann | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025↗ | O'Keefe Kenneth W | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | ORiordan Anne | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | RIEDEL NORBERT G | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Smith Mark Douglas | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Winningham Rick E | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 5, 2025↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 577 | $116.10 | $67.0K | 0 |
| Aug 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $113.21 | $113.2K | 0 |
| Jul 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $107.63 | $107.6K | 0 |
| Jun 2, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $108.95 | $109.0K | 0 |
| May 9, 2025↗ | Mulligan Seamus | Director | Buy | 101,621 | $98.34 | $9.99M | 0 |
| May 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $117.57 | $176.3K | 0 |
| Apr 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $123.75 | $185.6K | 0 |
| Mar 10, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 2,403 | $138.41 | $332.6K | 0 |
| Mar 7, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 2,473 | $138.04 | $341.4K | 0 |
| Mar 7, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 698 | $138.23 | $96.5K | 0 |
| Mar 5, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 22,251 | $138.95 | $3.09M | 0 |
| Mar 5, 2025↗ | GALA RENEE D | President & COO | Sell | 5,704 | $138.95 | $792.6K | 0 |
| Mar 5, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 12,319 | $138.75 | $1.71M | 0 |
| Mar 5, 2025↗ | Johnson Philip L | EVP & Chief Financial Officer | Sell | 1,149 | $138.95 | $159.7K | 0 |
| Mar 5, 2025↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 4,088 | $138.95 | $568.0K | 0 |
| Mar 5, 2025↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,905 | $138.95 | $264.7K | 0 |
| Feb 27, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 6,454 | $144.01 | $929.5K | 0 |
| Feb 27, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 6,500 | $144.25 | $937.6K | 0 |
| Feb 27, 2025↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,800 | $144.87 | $550.5K | 0 |
JAZZ Insider Buying Activity
The following table shows recent insider purchases of Jazz Pharmaceuticals plc (JAZZ) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 9, 2025↗ | Mulligan Seamus | Director | Buy | 101,621 | $98.34 | $9.99M | 0 |
JAZZ Insider Selling Activity
The following table shows recent insider sales of Jazz Pharmaceuticals plc (JAZZ) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026↗ | COZADD BRUCE C | Director | Sell | 17,453 | $171.16 | $2.99M | 0 |
| Jan 16, 2026↗ | GALA RENEE D | President & CEO | Sell | 5,371 | $171.16 | $919.3K | 0 |
| Jan 16, 2026↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 4,140 | $171.16 | $708.6K | 0 |
| Jan 16, 2026↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,275 | $171.16 | $560.5K | 0 |
| Jan 16, 2026↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,599 | $171.16 | $273.7K | 0 |
| Dec 9, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 2,238 | $169.51 | $379.4K | 0 |
| Dec 5, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 4,660 | $171.20 | $797.8K | 0 |
| Dec 5, 2025↗ | GALA RENEE D | President & CEO | Sell | 80 | $166.91 | $13.4K | 0 |
| Dec 2, 2025↗ | O'Keefe Kenneth W | Director | Sell | 603 | $173.07 | $104.4K | 0 |
| Nov 26, 2025↗ | COZADD BRUCE C | Director | Sell | 77,500 | $177.81 | $13.78M | 0 |
| Nov 20, 2025↗ | McSharry Heather Ann | Director | Sell | 3,415 | $177.78 | $607.1K | 0 |
| Nov 19, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 1,331 | $180.40 | $240.1K | 0 |
| Nov 18, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 5,319 | $182.06 | $968.4K | 0 |
| Nov 18, 2025↗ | COZADD BRUCE C | Director | Sell | 18,000 | $181.09 | $3.26M | 0 |
| Nov 18, 2025↗ | Winningham Rick E | Director | Sell | 5,500 | $180.86 | $994.7K | 0 |
| Nov 17, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 7,159 | $168.26 | $1.20M | 0 |
| Oct 1, 2025↗ | COZADD BRUCE C | Director | Sell | 5,500 | $137.01 | $753.6K | 0 |
| Sep 14, 2025↗ | COZADD BRUCE C | Director | Sell | 15,647 | $126.16 | $1.97M | 0 |
| Sep 2, 2025↗ | COZADD BRUCE C | Director | Sell | 6,000 | $128.62 | $771.7K | 0 |
| Aug 7, 2025↗ | Cook Jennifer E. | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | ENRIGHT PATRICK G | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Hamill Laura | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Kennedy Patrick | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025↗ | McSharry Heather Ann | Director | Sell | 1,959 | $111.25 | $217.9K | 0 |
| Aug 7, 2025↗ | O'Keefe Kenneth W | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | ORiordan Anne | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | RIEDEL NORBERT G | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Smith Mark Douglas | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 7, 2025↗ | Winningham Rick E | Director | Sell | 1,805 | $111.25 | $200.8K | 0 |
| Aug 5, 2025↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 577 | $116.10 | $67.0K | 0 |
| Aug 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $113.21 | $113.2K | 0 |
| Jul 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $107.63 | $107.6K | 0 |
| Jun 2, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,000 | $108.95 | $109.0K | 0 |
| May 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $117.57 | $176.3K | 0 |
| Apr 1, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 1,500 | $123.75 | $185.6K | 0 |
| Mar 10, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 2,403 | $138.41 | $332.6K | 0 |
| Mar 7, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 2,473 | $138.04 | $341.4K | 0 |
| Mar 7, 2025↗ | Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 698 | $138.23 | $96.5K | 0 |
| Mar 5, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 22,251 | $138.95 | $3.09M | 0 |
| Mar 5, 2025↗ | GALA RENEE D | President & COO | Sell | 5,704 | $138.95 | $792.6K | 0 |
| Mar 5, 2025↗ | Iannone Robert | EVP, Global Head of R&D & CMO | Sell | 12,319 | $138.75 | $1.71M | 0 |
| Mar 5, 2025↗ | Johnson Philip L | EVP & Chief Financial Officer | Sell | 1,149 | $138.95 | $159.7K | 0 |
| Mar 5, 2025↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 4,088 | $138.95 | $568.0K | 0 |
| Mar 5, 2025↗ | Pearce Samantha | EVP, Chief Commercial Officer | Sell | 1,905 | $138.95 | $264.7K | 0 |
| Feb 27, 2025↗ | Carr Patricia | SVP, Chief Accounting Officer | Sell | 6,454 | $144.01 | $929.5K | 0 |
| Feb 27, 2025↗ | COZADD BRUCE C | Chairman & CEO | Sell | 6,500 | $144.25 | $937.6K | 0 |
| Feb 27, 2025↗ | Patil Neena M | EVP & Chief Legal Officer | Sell | 3,800 | $144.87 | $550.5K | 0 |
JAZZ Insiders
Similar Stocks to JAZZ
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B